Bradykinin and nitric oxide in infectious disease and cancer

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 222-230

  Maeda, Hiroshi ^a   Akaike, Takaaki ^a   Wu, Jun ^a   Noguchi, Yoichiro ^a   Sakata, Yoshifumi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

bacterial dissemination; bacterial infection; bradykinin; Hageman factor; hypotension; kallikrein cascade; shock; tumor ascites; vascular permeability

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; BACTERIAL ENZYME; BLOOD CLOTTING FACTOR 12; BRADYKININ; CAPTOPRIL; COLLAGENASE; ENALAPRIL; ICATIBANT; KALLIKREIN; KALLIKREIN INHIBITOR; KININ; KININ ANTAGONIST; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PLASMINOGEN; PLASMINOGEN ACTIVATOR; POLYMER; PROCOLLAGENASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; SCAVENGER; SOYBEAN TRYPSIN INHIBITOR; TEICHOIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ASCITES; BACTERIAL CELL WALL; BACTERIAL INFECTION; BLOOD VESSEL PERMEABILITY; CANCER; CONFERENCE PAPER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYPOTENSION; INFLAMMATION; KALLIKREIN KININ SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PLEURISY; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0030175877     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00063-X     Document Type: Conference Paper

References (34)

1. • NO through a radical reaction, Biochemistry 32, 827.
2. Blast, F., 1988. Surface receptors for urokinase activator, Fibrinolysis 2, 73.
3. Bone, R.C., R.A. Balk, F.B. Cerra, R.P. Delinger, A.M. Fein, W.A. Knaus, R.M. Scheim and W.J. Sibbald, 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Chest 101, 1644.
4. de Bruin, P.A.F., G. Griffioen, H.W. Verspaget, J.H. Verheijen and C.B.H.W. Lamers, 1987. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa. adenomatous polyps, and adenocarcinomas, Cancer Res. 47, 4654.
5. Doi, K., T. Akaike, H. Horie, Y. Noguchi, S. Ijiri, T. Beppu, M. Ogawa and H. Maeda, 1995. Direct evidence for excessive production of nitric oxide in solid tumor in rats and its implication for solid tumor pathology, Cancer (in press).
6. Gohji, K., M. Nakajima, A. Fabra, C.D. Bucana, A.C. von Eschenbach, T. Tsuruo and I.J. Fidler, 1994. Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn. J. Cancer Res. 85, 152.
7. Greenbaum, L.M., G. Semente, P. Grebow and S. Roffman, 1978. The isolation of leukokinin-H and leukokininogen from human ascitic fluid: their properties and role, in: Kinin IJ, Advances in Experimental Medicine and Biology. Edited by S. Fujii.,H. Moriya and T. Suzuki (Plenum Press, N.Y.), 205.
8. Hasui, Y., J. Suzumiya, K. Marutsuka, A. Sumiyoshi, S. Hashida and E. Ishikawa, 1989. Comparative study of plasminogen activators in cancers and normal mucosa of human urinary bladder. Cancer Res. 49, 1067.
9. Holder, I. and A.N. Neely, 1992. Hageman factor dependent activation and its relationship to lethal Pseudomonas aeruginosa burn wound infection. in: Recent Progress on Kinin Part III. Edited by G. Bonner et al. (Birkhäuser-Verlag, Basel), 329.
10. Jänicke, F., M. Schmitt, K. Ulm, W. Gössner and H. Graeff, 1989. Urokinase-type plasminogen activator antigen and early relapse in breast cancer, Lancet II, 1048.
11. Kamata, R., T. Yamamoto, K. Matsumoto and H. Maeda, 1985. A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs. Infect. Immun. 48, 747.
12. Kuminishi, H., T. Cho, T. Itoh, A. Iwata, K. Kawasaki, Y. Hagihara and H. Maeda, 1993. Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs. FEMS Microbiol. Lett. 114, 109.
13. Kaminishi, H., H. Hamatake, T. Cho, T. Tamai, N. Suenaga, T. Fujii, Y. Hagihara and H. Maeda, 1994. Activation of blood clotting factors by microbial proteinases. FEMS Microbiol. Lett. 121, 327.
14. Katori, M., M. Majima, R. Odoi-Adome, N. Sunahara and Y. Uchida, 1989. Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Br. J. Pharmacol. 98, 1383.
15. Maeda, H., T. Akaike, Y. Sakata and K. Maruo, 1993. Role of bradykinin in microbial infection: Enhancement of septicemia by microbial proteases and kinin. in: Protease. Protease Inhibitor and Protease Derived Peptides: Importance in Human Pathophysiology and Therapeutics. Edited by J. Cheronis and J.E. Repine (Birkhäuser-Verlag, Basel), 159.
16. Maeda, H., K. Maruo, T. Akaike, H. Kaminishi and Y. Hagihara, 1992. Microbial proteinases as a universal trigger of kinin generation in microbial infections, in: Agents and Actions Supplements 38/III. Edited by G. Bonner, H. Fritz, B. Schoelkens, G. Dietze and K. Luppertz, 362.
17. 3]bradykinin in ascitic fluid from a patient with gastric cancer. J. Biol. Chem. 263, 16051.
18. Maeda, H. and K. Morihara, 1995. Serralysin and related bacterial proteinases. Methods Enzymol. 248, 395.
19. Maeda, H., Y. Noguchi, K. Sato and T. Akaike, 1994. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res. 85, 331.
20. Marian, B., S. Harvey, D. Infante, G. Markus, S. Winawer and E. Friedman, 1990. Urokinase secretion from human colon carcinomas induced by endogenous diglycerides. Cancer Res. 50, 2245.
21. Matsumoto, K., T. Yamamoto, R. Kamata and H. Maeda, 1984. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. J. Biochem. 96, 739.
22. Matsumura, Y., K. Maruo, M. Kimura, T. Yamamoto, T. Konno and H. Maeda, 1991. Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn. J. Cancer Res. 82, 732.
23. Molla, A., T. Yamamoto, T. Akaike, S. Miyoshi and H. Maeda, 1989. Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J. Biol. Chem. 264, 10589.
24. 1 proteinase inhibitor. Infect. Immun. 24, 188.
25. r receptor protein for urokinase-type plasminogen activator. J. Biol. Chem. 263, 2358.
26. Nilsson, T., J. Carlson and G. Sundqwist, 1985. Inactivation of key factors of the plasma protease cascade system by Bacterioides gingiralis. Infect. Immun. 50, 467.
27. Palmer, R.M.J., A.G. Ferrige and S. Moncada, 1987. Nitric oxide release account for the biological activity of endothelium-derived relaxing factor, Nature 327, 524.
28. 1-protease inhibitor by proteinases from Staphylococcus aureus. J. Biol. Chem. 261, 14330.
29. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto and M. Seiki, 1994. A matrix metalloprotease expressed on the surface of invasive tumor cells, Nature 370, 61.
30. Schlechte, W., G. Murano and D. Boyd, 1989. Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation. Cancer Res. 49, 6064.
31. Travis, J., J. Potempa and H. Maeda, Are bacterial proteases pathogenic factors? Trends Microbiol. (in press).
32. Vassalli, D.-D. and M.S. Pepper, 1994. Membrane proteases in focus. Nature 370, 14.
33. Yoshida, M., T. Akaike, Y. Wada, K. Sato, K. Ikeda, S. Ueda and H. Maeda, 1994. Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its radical nitric oxide-scavenging activity, Biochem. Biophys. Res. Commun. 202, 923.
34. Ziche, M., L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, C.A. Maggis, P. Geppetti and F. Ledda, 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 92, 2036.